Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
Clinical trial NCT00055874 · COMPLETED
Trial details
- NCT number
- NCT00055874
- Sponsor
- Heidelberg University
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-06-01
- Primary completion
- 2012-03-31
- Enrollment
- 1551
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.